Invesco Ltd. Acquires 192,802 Shares of Masimo Co. (NASDAQ:MASI)

Invesco Ltd. raised its stake in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 226.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 277,960 shares of the medical equipment provider's stock after buying an additional 192,802 shares during the quarter. Invesco Ltd. owned about 0.52% of Masimo worth $45,947,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of MASI. Stifel Financial Corp bought a new stake in Masimo in the third quarter valued at approximately $229,000. MML Investors Services LLC increased its position in shares of Masimo by 4.9% in the 3rd quarter. MML Investors Services LLC now owns 2,056 shares of the medical equipment provider's stock valued at $274,000 after buying an additional 96 shares in the last quarter. Barclays PLC raised its stake in Masimo by 152.6% during the 3rd quarter. Barclays PLC now owns 39,957 shares of the medical equipment provider's stock worth $5,329,000 after buying an additional 24,137 shares during the period. Geode Capital Management LLC grew its stake in Masimo by 1.5% in the third quarter. Geode Capital Management LLC now owns 792,886 shares of the medical equipment provider's stock valued at $105,741,000 after acquiring an additional 11,984 shares during the period. Finally, Tidal Investments LLC bought a new stake in shares of Masimo in the third quarter worth about $319,000. 85.96% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Masimo news, COO Bilal Muhsin sold 30,000 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $167.49, for a total value of $5,024,700.00. Following the sale, the chief operating officer now owns 24,172 shares in the company, valued at $4,048,568.28. This represents a 55.38 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Craig B. Reynolds sold 2,053 shares of Masimo stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $166.13, for a total value of $341,064.89. Following the transaction, the director now owns 16,581 shares of the company's stock, valued at $2,754,601.53. This represents a 11.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 16.90% of the company's stock.

Wall Street Analysts Forecast Growth

MASI has been the topic of several recent analyst reports. Wells Fargo & Company lifted their price objective on Masimo from $193.00 to $205.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. Needham & Company LLC reaffirmed a "hold" rating on shares of Masimo in a research note on Thursday, April 10th. Raymond James increased their price objective on shares of Masimo from $170.00 to $194.00 and gave the stock an "outperform" rating in a research report on Friday, December 27th. Finally, Piper Sandler boosted their price objective on shares of Masimo from $210.00 to $215.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, Masimo currently has an average rating of "Moderate Buy" and an average target price of $194.80.

Masimo Stock Down 3.7 %

Masimo stock traded down $5.66 during mid-day trading on Monday, reaching $146.49. The company's stock had a trading volume of 19,770 shares, compared to its average volume of 657,048. The business's 50 day simple moving average is $168.04 and its 200 day simple moving average is $165.13. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. Masimo Co. has a 12 month low of $101.61 and a 12 month high of $194.88. The company has a market capitalization of $7.92 billion, a price-to-earnings ratio of 101.08 and a beta of 1.28.

Masimo (NASDAQ:MASI - Get Free Report) last released its earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.38. The business had revenue of $600.70 million for the quarter, compared to the consensus estimate of $593.35 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. As a group, research analysts anticipate that Masimo Co. will post 4.1 earnings per share for the current year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.